Deakin University
Browse

Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients

Version 3 2024-06-19, 07:22
Version 2 2024-06-13, 15:03
Version 1 2022-10-31, 02:19
journal contribution
posted on 2024-06-19, 07:22 authored by K Butcher, BA Biggs, K Leder, C Lemoh, D O'Brien, C Marshall
Abstract Background Isoniazid treatment of latent tuberculosis infection (LTBI) is commonly prescribed in refugees and immigrants. We aimed to assess understanding of information provided about LTBI, its treatment and potential side effects. Methods A questionnaire was administered in clinics at a tertiary hospital. Total Knowledge (TKS) and Total Side Effect Scores (TSES) were derived. Logistic regression analyses were employed to correlate socio-demographic factors with knowledge. Results Fifty-two participants were recruited, 20 at isoniazid commencement and 32 already on isoniazid. The average TKS were 5.04/9 and 6.23/9 respectively and were significantly associated with interpreter use. Approximately half did not know how tuberculosis was transmitted. The average TSES were 5.0/7 and 3.5/7 respectively, but were not influenced by socio-demographic factors. Conclusions There was suboptimal knowledge about LTBI. Improvements in health messages delivered via interpreters and additional methods of distributing information need to be developed for this patient population.

History

Journal

BMC Research Notes

Volume

6

Article number

342

Pagination

342-

Location

England

ISSN

1756-0500

eISSN

1756-0500

Language

en

Publication classification

CN.1 Other journal article

Issue

1

Publisher

Springer Science and Business Media LLC